WWARN
Cross-source consensus on WWARN from 1 sources and 6 claims.
1 sources · 6 claims
Benefits
Background
Evidence quality
Where it comes from
Highlighted claims
- WWARN is a malaria-focused research platform hosted within the Infectious Diseases Data Observatory at the University of Oxford. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries
- Since 2009, WWARN has enabled IPD meta-analyses on safety, tolerability, and efficacy of several antimalarial drugs. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries
- WWARN-hosted data have informed WHO malaria treatment guidelines for paediatric populations. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries
- A 2013 WWARN IPD-MA on dihydroartemisinin-piperaquine dosing contributed to WHO guideline revisions beginning in 2015 for children with malaria. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries
- A WWARN IPD-MA found lower efficacy and lower post-treatment prophylaxis effects of artemisinin-based combination therapies in acutely malnourished children under 5. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries
- WWARN supports fair attribution to LMIC data contributors as part of sustaining data reuse. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries